# Monoclonal Antibody Followed by Bone Marrow Transplantation in Treating Patients With Acute Myelogenous Leukemia in Remission or First Relapse

> **NCT00002554** · PHASE2 · COMPLETED · sponsor: **Fred Hutchinson Cancer Center** · enrollment: 30 (estimated)

## Conditions studied

- Leukemia

## Interventions

- **DRUG:** busulfan
- **DRUG:** cyclophosphamide
- **DRUG:** methotrexate
- **PROCEDURE:** allogeneic bone marrow transplantation
- **RADIATION:** radioimmunotherapy

## Key facts

- **NCT ID:** NCT00002554
- **Lead sponsor:** Fred Hutchinson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1993-11
- **Primary completion:** 1999-12
- **Final completion:** 1999-12
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2010-03-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002554

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002554, "Monoclonal Antibody Followed by Bone Marrow Transplantation in Treating Patients With Acute Myelogenous Leukemia in Remission or First Relapse". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00002554. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*